Glenmede Trust Co. NA Sells 1,268 Shares of Waters Co. (NYSE:WAT)

Glenmede Trust Co. NA trimmed its position in Waters Co. (NYSE:WAT) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,007 shares of the medical instruments supplier’s stock after selling 1,268 shares during the quarter. Glenmede Trust Co. NA’s holdings in Waters were worth $34,912,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Summit Trail Advisors LLC grew its stake in shares of Waters by 2.4% during the third quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier’s stock worth $431,000 after purchasing an additional 28 shares during the period. OneDigital Investment Advisors LLC raised its position in shares of Waters by 3.8% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock valued at $306,000 after acquiring an additional 31 shares during the period. Raymond James Trust N.A. boosted its stake in Waters by 2.4% during the 3rd quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier’s stock worth $482,000 after acquiring an additional 32 shares during the last quarter. Linscomb Wealth Inc. increased its stake in Waters by 0.4% in the second quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier’s stock valued at $2,275,000 after purchasing an additional 34 shares in the last quarter. Finally, Johnson Investment Counsel Inc. boosted its position in shares of Waters by 3.2% during the second quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier’s stock worth $314,000 after purchasing an additional 34 shares in the last quarter. 94.01% of the stock is owned by institutional investors.

Waters Stock Down 0.4 %

Shares of NYSE WAT opened at $386.57 on Thursday. Waters Co. has a one year low of $273.60 and a one year high of $395.44. The business’s fifty day moving average price is $356.22 and its 200-day moving average price is $332.60. The stock has a market capitalization of $22.95 billion, a PE ratio of 36.89, a P/E/G ratio of 6.92 and a beta of 0.97. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38.

Waters (NYSE:WAT) last posted its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. The company had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.84 earnings per share. On average, equities research analysts anticipate that Waters Co. will post 11.79 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Jefferies Financial Group raised Waters from a “hold” rating to a “buy” rating and boosted their target price for the company from $355.00 to $415.00 in a research note on Tuesday, October 8th. Barclays boosted their price target on Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a report on Monday, November 4th. TD Cowen lifted their target price on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Leerink Partnrs raised shares of Waters from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, JPMorgan Chase & Co. raised their target price on shares of Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Waters has an average rating of “Hold” and a consensus target price of $365.85.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.